Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 10, 2021

SELL
$222.0 - $252.62 $52,614 - $59,870
-237 Closed
0 $0
Q3 2020

Oct 26, 2020

SELL
$175.56 - $226.45 $13,693 - $17,663
-78 Reduced 24.76%
237 $54,000
Q2 2020

Aug 11, 2020

BUY
$118.84 - $189.72 $15,568 - $24,853
131 Added 71.2%
315 $55,000
Q1 2020

May 06, 2020

BUY
$98.9 - $178.34 $18,197 - $32,814
184 New
184 $23,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.49B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Morgan Dempsey Capital Management LLC Portfolio

Follow Morgan Dempsey Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Dempsey Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Dempsey Capital Management LLC with notifications on news.